Annual ROE
-521.22%
-364.03%-231.59%
December 31, 2023
Summary
- As of February 8, 2025, VVOS annual return on equity is -521.22%, with the most recent change of -364.03% (-231.59%) on December 31, 2023.
- During the last 3 years, VVOS annual ROE has fallen by -348.66% (-202.05%).
- VVOS annual ROE is now -445.38% below its all-time high of -95.57%, reached on December 31, 2021.
Performance
VVOS ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-417.51%
+216.97%+34.20%
September 30, 2024
Summary
- As of February 8, 2025, VVOS quarterly return on equity is -417.51%, with the most recent change of +216.97% (+34.20%) on September 30, 2024.
- Over the past year, VVOS quarterly ROE has stayed the same.
- VVOS quarterly ROE is now -210.63% below its all-time high of 377.38%, reached on June 30, 2020.
Performance
VVOS Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
VVOS ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -231.6% | 0.0% |
| 3 y3 years | -202.1% | -328.7% |
| 5 y5 years | -198.1% | -56.8% |
VVOS ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -445.4% | at low | -417.6% | +45.9% |
| 5 y | 5-year | -445.4% | +54.4% | -210.6% | +45.9% |
| alltime | all time | -445.4% | +54.4% | -210.6% | +45.9% |
Vivos Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -417.51%(-34.2%) |
| Jun 2024 | - | -634.48%(-17.8%) |
| Mar 2024 | - | -771.50%(+63.1%) |
| Dec 2023 | -521.22%(+231.6%) | -473.04%(+46.1%) |
| Sep 2023 | - | -323.79%(+33.3%) |
| Jun 2023 | - | -242.97%(+37.8%) |
| Mar 2023 | - | -176.29%(+12.2%) |
| Dec 2022 | -157.19% | -157.11%(+29.4%) |
| Sep 2022 | - | -121.43%(+25.6%) |
| Jun 2022 | - | -96.67%(+12.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -85.67%(+6.2%) |
| Dec 2021 | -95.57%(-44.6%) | -80.67%(-17.2%) |
| Sep 2021 | - | -97.39%(-20.1%) |
| Jun 2021 | - | -121.87%(-54.2%) |
| Mar 2021 | - | -266.20%(-45.7%) |
| Dec 2020 | -172.56%(-84.9%) | -489.97%(-237.0%) |
| Sep 2020 | - | 357.70%(-5.2%) |
| Jun 2020 | - | 377.38%(+33.8%) |
| Mar 2020 | - | 282.00%(+45.1%) |
| Dec 2019 | -1141.81%(+553.1%) | 194.31% |
| Dec 2018 | -174.84% | - |
FAQ
- What is Vivos Therapeutics annual return on equity?
- What is the all time high annual ROE for Vivos Therapeutics?
- What is Vivos Therapeutics annual ROE year-on-year change?
- What is Vivos Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Vivos Therapeutics?
- What is Vivos Therapeutics quarterly ROE year-on-year change?
What is Vivos Therapeutics annual return on equity?
The current annual ROE of VVOS is -521.22%
What is the all time high annual ROE for Vivos Therapeutics?
Vivos Therapeutics all-time high annual return on equity is -95.57%
What is Vivos Therapeutics annual ROE year-on-year change?
Over the past year, VVOS annual return on equity has changed by -364.03% (-231.59%)
What is Vivos Therapeutics quarterly return on equity?
The current quarterly ROE of VVOS is -417.51%
What is the all time high quarterly ROE for Vivos Therapeutics?
Vivos Therapeutics all-time high quarterly return on equity is 377.38%
What is Vivos Therapeutics quarterly ROE year-on-year change?
Over the past year, VVOS quarterly return on equity has changed by 0.00% (0.00%)